What are the most recent 5 to 10 authoritative guidelines on chronic obstructive pulmonary disease (COPD) and their publication dates?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recent Authoritative COPD Guidelines

Based on the available evidence, the most recent authoritative guidelines on COPD published between 2016-2026 include approximately 8-10 major international and national guidelines, with publication dates ranging from 2016 to 2026.

Identified Guidelines and Publication Dates

Most Recent Guidelines (2022-2026)

  • Japanese Respiratory Society (JRS) Guidelines - 7th Edition (March 2026) 1

    • Incorporates GOLD 2023 etiotype classification
    • Addresses Japan-specific patient characteristics including lean body composition and high ACO prevalence
    • Includes 22 clinical questions (15 retained, 7 new)
  • Chinese Practice Guideline for COPD - 2026 Revision (planned publication 2026) 2

    • Registered at International Practice Guidelines Registry Platform (PREPARE-2026CN522)
    • Jointly developed by Chinese Thoracic Society and Chinese Association of Chest Physicians
    • Addresses 22 clinical questions using GRADE methodology
  • Spanish COPD Guidelines (GesEPOC) - 2025 Update 3

    • Published in Archivos de Bronconeumología
    • Uses GRADE methodology for 12 PICO questions
    • Introduces phenotype-based treatment approach (non-exacerbator, eosinophilic exacerbator, non-eosinophilic exacerbator)
  • New Zealand COPD Guidelines - 2025 Update 4

    • Published by Asthma and Respiratory Foundation NZ
    • Tailored to Aotearoa New Zealand clinical context
  • National Implementation Guideline for COPD in Primary Care (China) - 2025 5

    • Focuses on primary healthcare implementation
    • Integrates traditional Chinese medicine approaches
  • Canadian Thoracic Society (CTS) Guideline - 2023 6

    • Published in Chest
    • Focuses on pharmacotherapy in stable COPD
    • Updates 2019 recommendations with strong evidence for LAMA/LABA dual therapy
  • COPD-X Australian Guidelines - 2022 Update (Version 2.65) 7

    • Published by Lung Foundation Australia and Thoracic Society of Australia and New Zealand
    • Quarterly updates provided
    • Contains 26 recommendations across five domains

Earlier Guidelines (2011-2020)

  • British Thoracic Society Guideline for Long-term Macrolides - 2020 8

    • Published in Thorax
    • Specialized guideline addressing macrolide therapy in respiratory disease including COPD
  • European National Guidelines Review - 2016 9

    • Published in European Respiratory Journal
    • Reviewed guidelines from 11 European countries (Czech Republic, England/Wales, Finland, France, Germany, Italy, Poland, Portugal, Russia, Spain, Sweden)
    • Publication dates of reviewed guidelines ranged from 2007 (Germany) to 2015 (Finland)
  • Unified Guideline from ACP/ACCP/ATS/ERS - 2011 10

    • Published in Chest
    • Multi-society collaborative guideline
    • Updated previous ACP document from 2007

Important Context

The GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines, while referenced in multiple sources 11, are not explicitly detailed in the provided evidence but represent the most widely recognized international framework that many national guidelines reference or adapt.

The evidence demonstrates significant geographic variation in guideline development, with Asian-Pacific guidelines (Japan, China, Australia, New Zealand) showing the most recent updates (2022-2026), reflecting evolving understanding of regional patient characteristics and treatment responses 1, 3.

References

Research

[Chinese practice guideline for the diagnosis and treatment of chronic obstructive pulmonary disease (2026 revision): protocol].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2026

Research

[National implementation guideline for prevention and management of chronic obstructive pulmonary disease in primary care (2025)].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2026

Research

COPD: A Comprehensive Overview of a Prevalent Disease.

JAAPA : official journal of the American Academy of Physician Assistants, 2026

Related Questions

What is the RATE (Record, Assess, Treat, Ensure) protocol for chronic obstructive pulmonary disease (COPD)?
How do the most recent COPD guidelines differ from prior recommendations in terms of assessment, treatment choices, and recommendations, and which elements remain unchanged or remain controversial?
Can continuous positive airway pressure (CPAP) be used to treat chronic obstructive pulmonary disease (COPD)?
What is the recommended management for a moderate acute exacerbation of chronic obstructive pulmonary disease (COPD)?
What is the appropriate management for a 66-year-old patient with known chronic obstructive pulmonary disease who has cough, shortness of breath, wheezing, and dyspnea on exertion while walking?
What is the appropriate FOLFIRINOX dosing regimen administered via infusion pump for pancreatic adenocarcinoma in an adult patient?
What magnitude of ST‑segment elevation in the precordial leads is considered significant for men and women, and does meeting this threshold also indicate an acute ST‑elevation myocardial infarction?
I only have an IV cannula and no central line; how should I administer potassium chloride?
How do the most recent COPD guidelines differ from prior recommendations in terms of assessment, treatment choices, and recommendations, and which elements remain unchanged or remain controversial?
What should be done for a dialysis patient who develops fever and hypotension at home?
Does tacrolimus increase susceptibility to infections and delay wound healing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.